Abstract

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders

Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin

Issue: Mar/Apr 2010 - Compounding for Men

Page(s): 171-173

Download in electronic PDF format for $75
  • Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Page 1
  • Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Page 2
  • Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Page 3

Abstract

Use of low dose naltrexone has been advocated for a variety of medical problems. Only a few articles published in peer reviewed journals have documented side effects of low dose naltrexone. The purpose of this study was to determine the frequency of adverse effects of low dose naltrexone in patients who have been treated for a variety of gastrointestinal disorders. The secondary purpose was to determine global efficacy in a retrospective survey. Patients (206) from a single gastroenterologist’s clinical practice who had been prescribed naltrexone were mailed a survey to evaluate the side effects and efficacy of naltrexone. Patients had either irritable bowel syndrome without evidence for small intestinal bacterial overgrowth, irritable bowel syndrome with evidence of small intestinal bacterial overgrowth, chronic idiopathic constipation, or inflammatory bowel disease. Patients with diarrhea were given 2.5 mg daily, constipation 2.5 mg twice daily, and inflammatory bowel disease 4.5 mg daily. In the patients w

Related Keywords

  • low dose naltrexone
  • adverse effects
  • gastrointestinal disorders
  • irritable bowel syndrome
  • small intestine bacterial overgrowth
  • chronic idiopathic constipation
  • diarrhea
  • inflammatory bowel disease

Related Categories

  • GASTROENTEROLOGY
  • MENTAL HEALTH
  • PEER-REVIEWED
  • ADVERSE DRUG EVENTS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2010
Pg. 171-173
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
May/Jun 2016
Pg. 197-201
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Author(s): Sturn Kayla M, Collin Michael
Jul/Aug 2018
Pg. 270-278
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Nov/Dec 2023
Pg. 468-473
Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Author(s): Rodriguez Franklin, Carvalho Maria, Banov Fabiana
Mar/Apr 2020
Pg. 94-96
Low-dose Naltrexone Therapy for Psoriasis
Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Sep/Oct 2022
Pg. 378-384
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Author(s): Narváez Katherine Rivera, Thompson Tara
Mar/Apr 2012
Pg. 117-124
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Author(s): Zur Eyal
May/Jun 2018
Pg. 252-256
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia
Author(s): Cote Brianna, Ross Bethany, Fortner Jeff, Rao Deepa
Mar/Apr 2020
Pg. 104-108
Low-dose Pilocarpine Spray to Treat Xerostomia
Author(s): Zur Eyal
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jul/Aug 2023
Pg. 284-293
Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
Author(s): Riepl Mike, Kaiser Joe
Jul/Aug 2004
Pg. 313-319
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy
Author(s): Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J
Mar/Apr 2003
Pg. 129-134
View Sample
Basics of Compounding for Terrorist Attacks, Part 2
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Jan/Feb 2017
Pg. 6-16
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Author(s): Deleruyelle Laura J
Jul/Aug 2015
Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024
Pg. 111-116
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2019
Pg. 325-339
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Author(s): Glaser Rebecca L, York Anne E
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
May/Jun 2006
Pg. 195-200
Probiotic Therapy, Part 2: Clinical Perspectives
Author(s): Vail Jane